Lecture 11: Duchenne Muscular Dystrophy (an X-linked disease) Flashcards

1
Q

Summarise what is muscular dystrophy

A
  • Genetic disease affecting skeletal muscles
  • Characterized by progressive muscle weakness and wasting, and loss of motor skills
  • X-linked recessive most common: Duchenne and Becker (Becker is less severe)
  • More than 1 in 3500 males born
  • Onset age from infancy to adulthood
  • Most end up wheelchair-bound
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Define DMD

A
  • The most common of several childhood muscular dystrophies
  • An inherited disorder X-linked recessive with progressive degeneration of muscle
  • Onset is generally before age 6 years
  • Muscle loss usually not noticed until observation of unusual walking and/or talking around the age of 3
  • > parents spot issue first by comparing to siblings= allows early detection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

State the incidence rates of DMD for men and women

A
  • About 1 in every 3,500 to 5,000 males is born with DMD

- rarer for women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the phenotype of female carriers of DMD

A
  • Much rarer in females
  • > experience some symptoms: weaker muscles in the back, legs and arms that fatigue easily
  • > Carriers may have heart problems, shortness of breath or failure to do moderate exercise
    • heart problem picked later on in life or undetected
    • they try to avoid exercise-> because symptoms
  • > Untreated heart problems, can be serious, even life-threatening
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

State the cause of DMD

A
  • DMD caused by a mutation in the gene that produces an important muscle protein called dystrophin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe what dystrophin is

A
  • Muscles are made up bundles of muscle fibres
  • Interdependent proteins along the membrane surrounding each fiber- keep muscle cells working properly
    ->dystrophin is an interdependent protein
  • Dystrophin acts as a spring
  • When dystrophin missing = DMD
     Constant muscle contraction/ relaxation → weaken & destroys muscles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Explain the different types of muscular dystrophy

A
  • Becker muscular dystrophy - inability to produce functional dystrophin
  • Dystrophin: not 100% non-functional
  • Limited function = less severe
  • Duchenne muscular dystrophy – inability to produce dystrophin
  • No dystrophin production or production of only non-functional dystrophin
  • No function = more severe disease
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When do you suspect DMD and what are the ways of diagnosis

A

When:

  • if no family history of MD -> when not walking by >16-18 months
  • > Gowers’ signs
  • if pos. family history of MD-> any abnormal muscle function
  • patient has unexplained increase in transaminases

Screening:

  • creatine kinase
  • > conc. high= more testing
  • > conc. low= another diagnosis

Confim diagnosis:

  • testing for mutation found
  • muscle biopsy to see if dystrophin protein absent
  • gene sequencing if both test before doesn’t give results

Pos. result- confirmed
dystrophinopathy diagnosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Explain what happens after post-diagnosis

A
  • Muscle biopsy is optional -may distinguish DMD from milder phenotypes
  • Referral to specialist multidisplinary follow-up is required
  • Genetic counselling needs to be offered to any ‘at risk’ female family members
  • Patient and family support and contact with patient/family support organisations should be offered
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Give the clinical features of DMD

A
  • Early onset: signs appear before 6 years of age
  • Delayed development of motor skills
  • Difficulty in keeping balance
  • Progressive muscle weakness/fatigue
  • Respiratory muscles eventually involved in muscle weakness and fatigue
  • Pseudohypertrophy- enlargement of muscle tissue because it’s abnormal
  • Contractures- when elastic tissue of muscle is replaced by non-elastic tissue, making them remain too tight for too long and become shorter
  • Wheelchair dependent by early teens
  • Death usually in late teens, early twenties
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Give the symptoms of DMD

A
Early
-	Delayed Onset Walking
-	Difficulty in performing a standing jump
-	Waddling when walking (like penguin)
-	Difficulty standing up
-	Enlarged Calves-> pseudohypertrophy ( swollen due to muscle damage)
Later 
-	Difficulty getting up from a chair
-	Loss of ability to climb stairs
-	Wide gaited walk with balance problems

More symptoms

  • Fatigue
  • Mental retardation
  • Muscle weakness: begins in legs and pelvis, less severe in arms, neck
  • Poor motor skills (running, hopping, jumping)
  • Frequent falls
  • Rapidly worsening weakness
  • Progressive difficulty walking by age 10 may need braces soon after most confined to wheelchair
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe and explain what the Gower Manoeuvre is

A
  • Used to detect DMD
  • Uses more of upper body muscle than lower to stand-> sign of DMD
  • Immediate response-> roll over to use hands
  • Wide gait present throughout manoeuvre
  • Affected boys stand up by bracing their arms against their legs because of the weakness in the proximal muscles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Give the potential Complications of DMD

A
  • Scoliosis – Curvature due to contractures and muscle weakness
  • Cardiac
    – Dilated cardiomyopathy
    – Arrhythmia, shortness of breath and fatigue
  • Respiratory
    – Progressive weakening of the diaphragm
    – Pneumonia or other respiratory infections leads to:
    – Respiratory failure
  • Cognitive impairment (non-progressive)
  • Permanent, progressive disability
  • Decreased mobility
  • Decreased ability to care for self
  • Individuals affected by DMD killed by failure of the heart muscles usually by age 25
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain how muscle histology is used to diagnose DMD

A
  • Histology of normal (A) and DMD (B) muscle biopsies
  • Stained by H&E
    A:
  • Myofibers uniform size
  • evenly space
  • polygonal (uniform shape)
    B:
  • increased size variation - due to atropy and hypertropy
  • necrosis
  • fibrosis
  • fatty replacements
  • Muscle biopsies (brown stain)
  • Stained with antibody against dystrophin
    Normal:
  • Regular cellular architecture
  • dystrophin on all outer membranes
    DMD:
  • Irregular architecture
  • dystrophin absent from surface of muscle fibers
    Carrier:
  • Biopsy from a female carrier of DMD
  • patchy staining around outer cell membranes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How can DMD be inherited

A
  • female carriers
    -> because they have offspring who are affected or carriers
    -> obligate carriers of the disease gene
    x-linked recessive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How can DMD be inherited when both parents shown on pedigree as healthy

A
  • Could be de Novo or undiagnosed DMD female carrier

- Female carrier phenotypic consequence misdiagnosed

17
Q

Summarise the genetic consequences of MD

A
  • Main cause:
    – X-linked disease
    –recessive mutation in X-chromosome ->Inherited from parents
  • Females affected only if both X-chromosomes mutated
    – Single mutation: normal as enough functional dystrophin produced
    -> Usually unaffected, but a carrier of disease = have phenotypic consequence
    – Double mutation-> affected
    ->very unlikely
  • Males – single X-chromosome
    – Mutation in X-chromosome = no dystrophin production
18
Q

Summarise the inheritance of MD

A
  • Unaffected carrier mother + unaffected father
    – Mother: 1 mutated X-chr + 1 normal X-chr
    – Father: 1 normal X-chr + 1 normal Y-chr
  • Unaffected female
    – Normal X-chr from mother + normal X-chr from father
  • Carrier female
    – Normal X-chr from father + mutated X-chr from mother
    – Normal X-chr = enough functional dystrophin produced
  • Unaffected male
    – Normal X-chr from mother + normal Y-chr from father
  • Affected male
    – Mutated X-chr from mother + normal Y-chr from father
    = No normal X-chr = no dystrophin production
19
Q

Explain how DMD gene discovered and identified

A
  • Chromosomal abnormality= boy- visible deletion at Xp21.3
    = woman- balanced Xp21;21p12 translocation
  • Identified by positional cloning= chrom. Abnormality show to have giant implications on dystrophin gene
  • Has large no. exons + average small size for each of them
  • Usually size larger
  • Balanced translocations and inversions-> very useful = no net loss of DNA
  • The underlying gene is expected to be close to or located at breakpoint
20
Q

Describe the structure of dystrophin

A
  • Functionally important domains are in the N- and C-terminal regions
  • Dystrophin protein- forms a structural link between actin filaments of the cytoskeleton and the extracellular matrix
  • > via a membrane bound dystrophin-associated protein (DAP) complex
21
Q

Explain the functional role of dystrophin

A
  • Dystrophin anchors the cytoskeleton of muscle cells to the extracellular matrix
  • > via the dystrophin glycoprotein complex
  • Complex includes sarcoglycans (mutations cause limb-girdle muscular dystrophies) + dystroglycans
  • Muscle cells that lack dystrophin:
  • > mechanically fragile
  • > fail after a few years= progressive weakness
22
Q

Explain how the deletions in dystrophin gene lead to DMD

A
  • Large In-frame deletions of central exons in the dystrophin gene:
  • Can remove many of the central exons
  • Reading frame is not disrupted =associated with Becker muscular dystrophy
  • There is no premature termination codon (TER)
  • Exons at front + back of deletion join
  • Large out of frame deletions of central exons in the dystrophin gene:
  • Can remove many of the central exons
  • If a single central exon deleted where the nucleotides lost is not divisable by 3= frame shift
  • Premature termination codon (pTER) follows-often next exon triggering nonsense-mediated decay of dystrophin mRNA
  • Ensures failure to make any protein = causing DMD
23
Q

Explain how DMD can be diagnosed

A
  • Blood Creatine phosphokinase (CPK) test
  • Damaged muscles can release creatine kinase into blood
  • Elevated levels ->muscle injury: trauma or muscular dystrophy
  • Electromyography (EMG)
  • Measuring electric signaling to and from the muscle
  • rule out neurodegenerative diseases +confirm a muscle disease
  • Muscle biopsy
  • Microscopic analysis of a sample of muscle tissue
  • identify absence of dystrophin + characteristics associated with muscular dystrophies
  • Genetic testing
  • Testing for mutations in muscular dystrophy related genes
  • Determine the exact form of muscular dystrophy
24
Q

Explain how exon deletions in DMD are screened

A

PCR

  • Exon-specific primers used
  • Based on:
  • > 9 selected exons of the dystrophin gene were amplified from the DNA of affected
  • PCR product run on an electrophoretic gel
  • > Each exon gives a band of a characteristic size
  • ALWAYS NEED MARKER LANE-> many fragments of known size
  • Boys have 1 X chrom. ->any deletion shows as missing bands
  • Exon deletions arrowed
    ->Lane 3: large deletion or a technical failure?
  • Boys with no deletions:
    -> may have deletions in other exons
    ->OR point mutations
    -> OR duplications
    = causing loss of function
25
Q

Explain the principles of MLPA

A
  • Detects copy number changes over a broad range of DNA lengths
  • Can scan for intragenic deletions and duplications by assessing copy number of exons
  • Useful for disorders with high frequency intragenic deletions ->DMD
  • Use alongside DNA sequencing to scan for point mutations
  • Sample DNA placed in thermocycler+ heated= DNA strands separate= denaturation
  • Probes added to sample DNA and target multiple exons
  • > probes are paired
  • > probe has stuffer fragment- each probe has unique length= amplification product of probe can be identified
  • Hybridise overnight
  • > hybridise to adjacent sequences within target
  • DNA ligase added to mixture-> ligates pair of probes together
  • Probe amplified by PCR
  • > DNAP + DNA nucleotides + forward and reverse primers added-> forward primer fluorescently labelled
  • Capillary electrophoresis separates PCR products
  • > uses standard sized fragments that have different label
26
Q

Explain how results from MLPA can be used to diagnose DMD

A
  • Capillary electrophoresis
  • Paired red (normal) and blue peaks (sample) (125–475 bp) = individual exons
  • Large exons can require partly overlapping probes
  • Deletion of seven exons (arrowed) is shown: blue peak reduced by ~50% -heterozygous deletion
  • Peak order is sometimes not the same as for gene exons
27
Q

How can you distinguish between homozygous and heterozygous deletions

A
  • Homozygous= complete deletion of peak

- Heterozygous= peak reduced by 50%

28
Q

Give the different DNA analysis that is used for MD

A
  • MPLA->for deletions of exons and duplications
  • > for DMD and BMD
  • direct sequencing-> small variations
  • Immunochemistry- H&E and monoclonal antibodies
29
Q

Outline the mechanism for DMD

A
  • Mechanical stress caused by dystrophin absence
  • leads to sarcolemmal disruption + calcium channel activation
  • Increased intracellular calcium
  • > activates:
  • calcium-dependent proteases
  • chemokines
  • cytokines
  • Inflammation and necrosis retards muscle regeneration
  • Necrosis accompanied by fibrosis and fatty tissue infiltration in muscle
  • Fibrosis: formation of excess fibrous connective tissue in an organ or tissue in a reparative or reactive process